Table 1. Labeling efficiency and specific activity of DFO-nimotuzumab kit formulation.

Amount of antibody (μg) per 10 MBq	Labeling efficiency % ± SD	Specific activity (MBq/μg)
5	21 ± 1.1	2.0
10	86 ± 1.0	1.0
20	91 ± 1.2	0.5
50	92 ± 0.4	0.2
100	94 ± 0.9	0.1